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Systems biology analyses in cancer are
rapidly changing from merely descriptive
efforts in the high-throughput exper-
imental works and overtly technical,
calculation-centered studies in compu-
tational systems biology; toward a more
functional, mechanistic paradigm. The
ultimate goal of cancer systems biology
nowadays is thus, unraveling the mech-
anisms of action, regulation and control
in the complex tangle of biochemical and
biophysical interactions behind cancer
biology. An outstanding example of this
trend is given in the paper by Kessler
and coworkers (2013). On this work, the
authors combine ideas from gene expres-
sion profiling for phenotypic classification
(Hedenfalk, 2002; Subramanian et al.,
2005), of signaling pathways (Haynes
et al., 2013; Leiserson et al., 2013) and of
network modularity (Hintze and Adami,
2008; Jiang et al., 2008), in order to show
how molecular physiology (i.e., under-
standing the physiological mechanisms
of disease from a molecular standpoint)
may have many clues leading to better
prognosis and treatment of cancer.
Interesting issues arise in the modeling
of such complex processes. For instance,
the fact that mRNA expression levels for
the molecules involved in a given signal-
ing pathway might be enough to give a
proper image of the activity status of such
pathway on tumor samples. Since whole
genome gene expression analysis is a quite
standardized procedure, both in research
and in clinical instances, whereas quan-
titative proteomic and fluxomic analyses
are not (Guerrasio et al., 2013; Nargund
et al., 2013), this is really good news
that, nevertheless should be taken cum
grano salis. The relationship between sig-
naling networks, transcriptional networks
and biochemical/metabolic pathways (that
in the living cells correspond to one uni-
fied machinery notwithstanding the frag-
mented view that we used to have on
them) (Baca-López et al., 2012) is of fore-
most importance for the clinic, since opens
the way to drugs designed to inhibit recep-
tor coupled signaling that may lead to
improving our therapeutic interventions.
This relationship, systemic and physiolog-
ical in nature, was exploited by Kessler
et al. to develop their optimized sample-
stratification strategy.
While, in principle, their work provides
a clustering/stratification/classification
method based in gene expression sig-
natures (of which there are quite a few,
some of them very efficient) (see for
instance, Subramanian et al., 2005); the
scope of it is much wider. As the title
points out, there is a definite integrative
view behind their computational anal-
yses, one in which transcriptional and
signaling networks, biochemical pathways
and computationally-derived modules are
interconnected to unveil physiological
issues behind the behavior of differ-
ent tumor phenotypes. Such differences
in the molecular mechanisms (and not
some computationally-derived quantita-
tive index, devoid of biological meaning)
are the ones that ultimately determine
the tumor phenotypes and, as such, they
seem to be the obvious optimum classi-
fiers. While this is not the always case at
the present moment, some of us believe
there are reasons still to be (moderately)
optimistic.
For instance, Kessler et al.’s classifier
does not perform quantitatively better
that its gene-centered counterparts (its
quantitative performance just equals the
one of its rival methods), but in com-
pensation performs qualitatively better
in that it provides (by means of explicit
pathway reconstruction/recognition) tools
that may be used to develop further bio-
logical insight in the phenomena. One
may argue, however, that one of the
reasons for current quantitative deficien-
cies in pathway-oriented approaches to
outperform gene-centered ones, is the
fact that annotation databases for indi-
vidual molecules are currently much
better curated than pathway databases.
Other factors may be the methods for
pathway reconstruction (often proba-
bilistic in nature) and the presence of
crosstalk/crosslink phenomena.
The manuscript by Kessler et al, is
also a good example of the combina-
tion of data-driven approaches (common
in computational biology) working in
addition to (or if you wish on top of)
hypothesis-driven research. The authors
decided to study whole genome expres-
sion profiles, yet since they were interested
in the role of signaling dynamics, they
choose to focus on a core network centered
in kinase activity and serine/threonine
kinase receptors supplemented with well-
known signaling processes in cancer that
do not rely on kinase dynamics, such as
the Notch, Hedgehog and Wnt pathways.
By doing this, they introduce modeling
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hypotheses that induce a structure in the
network modules that they will ana-
lyze later; namely a LIGAND/RECEPTOR/
ADAPTOR generalistic mechanism, some-
times supplemented with CoActivators
and CoInhibitors. The rationale behind
this was that . . . separating indirectly acti-
vating and inhibiting factors from path-
way core modules allows assessment of the
functional importance of a module through
different levels of the network hierarchy. . .
thus permitting a better optimized anal-
ysis of such modules. Then they use the
module-based network activity as a proxy
to mimick the activity of the signaling
pathways, yet in my opinion the authors
could have gone even one step further
in discussing the functional roles of the
pathways that their method identified.
For instance, by discussing the poten-
tial interactions between the AKT and
RAS pathways, or the verstaile role of
PDGFR as concertator in a number of
biological processes and how did these
phenomena may affect their classification
strategies.
All in all, the authors are taking defi-
nite steps advancing into a more physio-
logical, mechanistic approach to compu-
tational systems biology (approach that I
personally share and envision in my cur-
rent research) that I like to see as the
In silico version of Functional Genomics;
I’d like to call this approach Functional
Systems Biology. Themanuscript by Kessler
et al. provides a nice example of the state-
of-the-art of such a nascent discipline.
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